Ranibizumab Intraocular and Succinylcholine Chloride
Determining the interaction of Ranibizumab Intraocular and Succinylcholine Chloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: succinylcholine
Brand name: Anectine, Quelicin
Synonyms: Succinylcholine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Succinylcholine Chloride Injection
- Ranibizumab Intraocular-Suclear
- Ranibizumab Intraocular-Sucralfate
- Ranibizumab Intraocular-Sucralfate Oral Suspension
- Ranibizumab Intraocular-Sucralfate Suspension
- Ranibizumab Intraocular-Sucralfate Tablet
- Succinylcholine Chloride-Ranibizumab ophthalmic
- Succinylcholine Chloride-Ranitidine
- Succinylcholine Chloride-Ranitidine Capsule
- Succinylcholine Chloride-Ranitidine Hydrochloride
- Succinylcholine Chloride-Ranitidine Injection
- Succinylcholine Chloride-Ranitidine Suspension